Bone Biologics BBLG Stock
Bone Biologics Price Chart
Bone Biologics BBLG Financial and Trading Overview
| Bone Biologics stock price | 0.66 USD |
| Previous Close | 3.93 USD |
| Open | 1.84 USD |
| Bid | 0 USD x 900 |
| Ask | 0 USD x 1000 |
| Day's Range | 1.6 - 1.91 USD |
| 52 Week Range | 1.6 - 59.1 USD |
| Volume | 1.53M USD |
| Avg. Volume | 77.66K USD |
| Market Cap | 913.09K USD |
| Beta (5Y Monthly) | 0.810211 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -4.83 USD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 40.88 USD |
BBLG Valuation Measures
| Enterprise Value | -4000240 USD |
| Trailing P/E | N/A |
| Forward P/E | -0.25826773 |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | N/A |
| Price/Book (mrq) | 0.3293834 |
| Enterprise Value/Revenue | N/A |
| Enterprise Value/EBITDA | N/A |
Trading Information
Bone Biologics Stock Price History
| Beta (5Y Monthly) | 0.810211 |
| 52-Week Change | -95.82% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 59.1 USD |
| 52 Week Low | 1.6 USD |
| 50-Day Moving Average | 6.13 USD |
| 200-Day Moving Average | 12.15 USD |
BBLG Share Statistics
| Avg. Volume (3 month) | 77.66K USD |
| Avg. Daily Volume (10-Days) | 371.99K USD |
| Shares Outstanding | 556.76K |
| Float | 336.65K |
| Short Ratio | 0.32 |
| % Held by Insiders | N/A |
| % Held by Institutions | N/A |
| Shares Short | 13.67K |
| Short % of Float | 5.34% |
| Short % of Shares Outstanding | 2.46% |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor | 1:30 |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2022 |
| Most Recent Quarter (mrq) | March 31, 2023 |
| Next Fiscal Year End | December 31, 2023 |
Profitability
| Profit Margin | 0% |
| Operating Margin (ttm) | 0% |
| Gross Margin | 0% |
| EBITDA Margin | 0% |
Management Effectiveness
| Return on Assets (ttm) | -59.43% |
| Return on Equity (ttm) | -102.25% |
Income Statement
| Revenue (ttm) | N/A |
| Revenue Per Share (ttm) | N/A |
| Quarterly Revenue Growth (yoy) | N/A |
| Gross Profit (ttm) | N/A |
| EBITDA | N/A |
| Net Income Avi to Common (ttm) | -4505020 USD |
| Diluted EPS (ttm) | -7.47 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 6.19M USD |
| Total Cash Per Share (mrq) | 11.12 USD |
| Total Debt (mrq) | 0 USD |
| Total Debt/Equity (mrq) | N/A |
| Current Ratio (mrq) | 1.691 |
| Book Value Per Share (mrq) | 4.979 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -4056127 USD |
| Levered Free Cash Flow (ttm) | -485640 USD |
Profile of Bone Biologics
| Country | United States |
| State | MA |
| City | Burlington |
| Address | 2 Burlington Woods Drive |
| ZIP | 01803 |
| Phone | 781-552-4452 |
| Website | https://www.bonebiologics.com |
| Industry | Medical Devices |
| Sector(s) | Healthcare |
| Full Time Employees | 2 |
Bone Biologics Corporation, a medical device company, focuses on bone regeneration in spinal fusion using the recombinant human protein. The company's NELL-1/DBM, an osteopromotive recombinant protein that provides target specific control over bone regeneration. It also develops NELL-1/DBM Fusion Device for use in spinal fusion procedures in skeletally mature patients with degenerative disc disease at one level from L2-S1. The company's platform technology is used in delivering enhanced outcomes in the surgical specialties of spinal, orthopedic, general orthopedic, plastic reconstruction, neurosurgery, interventional radiology, and sports medicine. It has a license agreement with the UCLA Technology Development Group to develop and commercialize NELL-1 for spinal fusion applications. Bone Biologics Corporation was founded in 2004 and is headquartered in Burlington, Massachusetts.
Q&A For Bone Biologics Stock
What is a current BBLG stock price?
Bone Biologics BBLG stock price today per share is 0.66 USD.
How to purchase Bone Biologics stock?
You can buy BBLG shares on the NasdaqCM exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Bone Biologics?
The stock symbol or ticker of Bone Biologics is BBLG.
Which industry does the Bone Biologics company belong to?
The Bone Biologics industry is Medical Devices.
How many shares does Bone Biologics have in circulation?
The max supply of Bone Biologics shares is 3.28M.
What is Bone Biologics Price to Earnings Ratio (PE Ratio)?
Bone Biologics PE Ratio is now.
What was Bone Biologics earnings per share over the trailing 12 months (TTM)?
Bone Biologics EPS is -4.83 USD over the trailing 12 months.
Which sector does the Bone Biologics company belong to?
The Bone Biologics sector is Healthcare.
Bone Biologics BBLG included in indexes
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume |
|---|
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume | |
|---|---|---|---|---|---|---|---|
| {{ item.name }} {{ item.symbol }} | {{ item.price }} {{ item.price_usd }} |
{{ item.change_pct }}
|
{{ item.volume }} {{ item.volume_usd }} | {{ item.low }} {{ item.low_usd }} | {{ item.high }} {{ item.high_usd }} | {{ item.components_count }} - | {{ item.volume }} {{ item.volume_usd }} |
| NASDAQ Composite IXIC | 17366.13 USD — |
-0.1
|
9.58B USD — | 17128.71 USD — | 17467.35 USD — | — - | 9.58B USD — |
| NASDAQ HealthCare IXHC | 931.02 USD — |
+0.81
|
— — | 921.75 USD — | 934.48 USD — | — - | — — |
- {{ link.label }} {{link}}